Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 8,478 shares at $16.74 ($143K) on 2022-10-10, disclosed to the SEC on 2022-10-12.
Open-market sale of $143k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.74 | 3,524 | $59K | 41.3% |
| 2 | $16.74 | 3,524 | $59K | 41.3% |
| 3 | $17.27 | 1,430 | $25K | 17.3% |
| Total | $16.83 avg | 8,478 | $143K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |